Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- efgartigimod alfa / hyaluronidase
- saccharomyces boulardii lyo
Interactions between your drugs
saccharomyces boulardii lyo efgartigimod alfa
Applies to: saccharomyces boulardii lyo, efgartigimod alfa / hyaluronidase
If you are currently being treated or have recently been treated with efgartigimod alfa, you should let your doctor know before using saccharomyces boulardii lyo. Depending on the dose and length of time you have been on efgartigimod alfa, you may be at risk for developing rare infections from exposure to products containing live bacteria or yeast. Depending on your overall health and medical condition, it may be advisable to avoid using saccharomyces boulardii lyo until your immune system has recovered from the effects of efgartigimod alfa. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Hizentra
Hizentra (immune globulin) is used as a replacement therapy in patients with primary humoral ...
Privigen
Privigen is used to treat primary immune deficiency conditions and idiopathic thrombocytopenic ...
Gammagard Liquid
Gammagard (immune globulin) is used to treat primary immune deficiency and multifocal motor ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.